| Name | Title | Contact Details |
|---|
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer`s 2009 sales were approximately $4.1 billion. The Company is supported by the efforts of approximately 8,500 employees worldwide.
We help people find and maintain recovery from substance misuse through peer relationships. Recovree provides services to support the health and wellness of employees including on-demand access to recovery coaches with lived-experience, comprehensive chemical health assessments, and incident response planning. Employees struggling with drug and alcohol addiction can have a significant impact on a company`s productivity, safety and culture. Our services help employers retain top talent, improve the health and wellness of their teams and provide better access to resources for people who need help now. Check out our Recovery Friendly Workplace Toolkit, where we introduce you to the disease of substance use disorder, its impact in the workplace, and how to create and support a recovery friendly workplace. Our goal is to provide you with practical tools and information that you can implement within your company. We want to help you improve the lives of your employees and save money.
Data R X Management is a Cumming, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
ASI Benefits, Your Total Health Coverage Solution is a Fresno, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.